Article Versions Notes

Pezzoli A, Abenavoli L, Scarcella M, Rasetti C, Svegliati Baroni G, Tack J, Scarpellini E. The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels. Medicina. 2025; 61(3):387. https://doi.org/10.3390/medicina61030387

Pezzoli, Annalisa, Ludovico Abenavoli, Marialaura Scarcella, Carlo Rasetti, Gianluca Svegliati Baroni, Jan Tack, and Emidio Scarpellini. 2025. "The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels" Medicina 61, no. 3: 387. https://doi.org/10.3390/medicina61030387

Pezzoli, A., Abenavoli, L., Scarcella, M., Rasetti, C., Svegliati Baroni, G., Tack, J., & Scarpellini, E. (2025). The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels. Medicina, 61(3), 387. https://doi.org/10.3390/medicina61030387